https://www.oxfordbiodynamics.com/ https://www.oxfordbiodynamics.com/about-us https://www.oxfordbiodynamics.com/about-us/historical-timeline https://www.oxfordbiodynamics.com/about-us/leadership-team https://www.oxfordbiodynamics.com/about-us/board-of-directors https://www.oxfordbiodynamics.com/about-us/advisory-panel https://www.oxfordbiodynamics.com/products-services https://www.oxfordbiodynamics.comhttps://www.mycirt.com/ https://www.oxfordbiodynamics.comhttps://www.94percent.com https://www.oxfordbiodynamics.com/products-services#episwitch-mecfs https://www.oxfordbiodynamics.comhttps://www.episwitchorion.com/ https://www.oxfordbiodynamics.comhttps://store.oxfordbiodynamics.com/products/episwitch%C2%AE-explorer-array-kit https://www.oxfordbiodynamics.com/products-services/specimen-submission-kit https://www.oxfordbiodynamics.comhttps://store.oxfordbiodynamics.com/ https://www.oxfordbiodynamics.com/episwitch-platform https://www.oxfordbiodynamics.com/media-center/in-the-news https://www.oxfordbiodynamics.comhttps://intheloop.oxfordbiodynamics.com https://www.oxfordbiodynamics.com/media-center/regulatory-news https://www.oxfordbiodynamics.com/media-center/publications https://www.oxfordbiodynamics.com/investors https://www.oxfordbiodynamics.com/investors/news-events/regulatory-news https://www.oxfordbiodynamics.com/investors/news-events/email-alerts https://www.oxfordbiodynamics.com/investors/company-information https://www.oxfordbiodynamics.com/investors/company-information/leadership-team https://www.oxfordbiodynamics.com/investors/company-information/contacts https://www.oxfordbiodynamics.com/investors/company-information/faq https://www.oxfordbiodynamics.com/investors/financial-results https://www.oxfordbiodynamics.com/investors/stock-data/quote https://www.oxfordbiodynamics.com/investors/stock-data/charts https://www.oxfordbiodynamics.com/investors/stock-data/historical-data https://www.oxfordbiodynamics.com/investors/aim-rule-26 https://www.oxfordbiodynamics.com/investors/corporate-governance https://www.oxfordbiodynamics.com/investors/corporate-governance/board-of-directors https://www.oxfordbiodynamics.com/investors/corporate-governance/governance-structure https://www.oxfordbiodynamics.com/investors/corporate-governance/governance-documents https://www.oxfordbiodynamics.com/investors/corporate-governance/corporate-governance-statement https://www.oxfordbiodynamics.com/investors/corporate-governance/whistleblower-policy https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24394/qa-how-a-noninvasive-blood-test-is-changing-immunotherapy-treatment https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24395/oxford-biodynamics-a-winning-trifecta-of-technology-story-and-strong-management https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24396/2-moonshot-biotechs-with-10x-potential https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24397/noninvasive-detection-of-biomarkers-may-improve-als-diagnosis-study-reports https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24398/obd-joins-imperial-in-a-prostate-cancer-trial https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24399/biomarkers-may-determine-als-progression-edaravone-response https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24400/dr-steven-mamus-smart-test-promises-to-transform-how-we-recommend-and-administer-immunotherapy https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24401/episwitch-test-may-help-classify-als-patients-new-trial-data https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24402/the-race-to-uncloak-cancer-with-liquid-biopsies https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24403/scientists-hope-new-test-could-aid-detection-of-prostate-cancer-in-black-men https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24404/launch-of-hippocrates-a-new-21-million-eu-and-industry-funded-psoriatic-arthritis-research-project-led-by-university-college-dublin https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24405/oxford-biodynamics-covid-severity-test-demonstrates-92-accuracy https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24406/the-top-10-biotech-companies-brewing-at-oxford https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24407/glasgow-university-professor-joins-advisory-board-of-pioneering-biotech-firm https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24408/oxford-biodynamics-to-use-new-technology-as-partner-in-refine-als-biomarker-study https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24409/queens-awards-success-for-businesses-backed-by-innovate-uk https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24410/the-high-tech-hunt-for-new-biomarkers https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24411/oxford-biodynamics-launches-episwitch-cirt-in-us https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24412/oxford-firm-develops-better-test-for-als-diagnosis https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24413/study-identifies-biomarker-for-the-diagnosis-of-amyotrophic-lateral-sclerosis-als https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24414/new-test-to-tackle-staggering-prostate-cancer-rates-in-black-men-being-developed https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24415/blood-based-biomarkers-may-predict-disease-response-in-advanced-urothelial-carcinoma https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24416/epigenetic-biomarkers-predict-immunotherapy-success https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24417/interview-oxford-biodynamics-highly-promising-new-approach-als-diagnosis https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24418/study-finds-biomarker-that-could-speed-up-diagnosis-of-motor-neurone-disease https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24419/interview-oxford-biodynamics-extending-precision-medicine-study https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24420/qa-with-dr-alexandre-akoulitchev-chief-scientific-officer-at-oxford-biodynamics-plc https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24421/oxford-biodynamics-attracts-the-big-guns-of-global-pharma https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24422/breakthrough-in-the-war-on-skin-cancer-thousands-of-lives-could-be-saved-after-scientists-develop-a-simple-blood-test-to-detect-most-deadly-form https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24423/oxford-biodynamics-presents-applications-of-its-epigenetic-biomarker-technology-episwitch-at-the-annual-meeting-of-the-american-society-of-hematology-in-san-diego https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24424/oxford-biotech-spinout-biodynamics-to-list-on-stock-market https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24425/advancing-cancer-care-with-3d-genomics https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24426/new-prostate-cancer-test-is-94-accurate-and-could-stop-unnecessary-biopsies-researchers-say https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24427/oxford-biodynamics-prostate-screening-episwitch-blood-test-significantly-enhances-overall-detection-accuracy-for-at-risk-men https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24428/new-prostate-cancer-test-could-spare-men-from-needless-biopsies https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24429/scientists-create-impressive-new-blood-test-for-prostate-cancer-that-is-94-accurate https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24430/new-prostate-cancer-blood-test-combining-psa-with-epigenetic-test-could-reduce-biopsies https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24447/qa-analyzing-blood-not-the-tumor-a-novel-test-for-personalized-cancer-immunotherapy https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24470/new-blood-test-for-prostate-cancer-claims-94-accuracy https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24474/new-liquid-biopsy-test-can-improve-prostate-cancer-test-accuracy-from-55-to-94-revolutionary-test-based-on-3d-genomics-is-described-at-precision-medicine-world-conference-pmwc-2024 https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24483/oxford-biodynamics-part-of-consortium-shortlisted-for-strategic-government-initiative-to-improve-cancer-immunotherapy https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24487/i-tried-the-new-blood-test-for-prostate-cancer-heres-what-you-need-to-know https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24488/what-your-psa-test-says-about-your-prostate https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24489/episwitch-prostate-screening-pse-blood-test https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24504/new-prostate-cancer-test-cuts-biopsies-by-50-in-us-real-world-use https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24502/new-prostate-cancer-test-cuts-biopsies-by-50-in-us https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24503/prostate-cancer-blood-test-with-unprecedented-accuracy-cuts-biopsies-by-50 https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24506/revolutionary-prostate-cancer-test-set-to-save-thousands-of-lives https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24511/oxford-biodynamics-crc-diagnostic-test-could-reduce-unnecessary-patient-follow-ups https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24514/revealed-rishi-sunaks-first-major-cause-after-no-10---as-cancer-crusader https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24515/rishi-sunak-too-many-men-are-still-dying-of-embarrassment-over-prostate-cancer-thats-why-im-calling-for-health-chiefs-to-launch-a-national-screening-programme https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24516/sunak-becomes-prostate-cancer-charity-ambassador https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24534/breakthrough-british-prostate-cancer-test-could-avoid-need-for-biopsies-in-80pc-of-men https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24542/oxford-biodynamics-chair-on-key-collaboration-with-google-cloud https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24543/kashyap-patel-using-the-episwitch-cirt-test-to-assess-the-likelihood-of-response-to-immunotherapy https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24552/scientists-develop-first-ever-blood-test-to-diagnose-chronic-fatigue-syndrome https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24551/breakthrough-as-scientists-develop-first-ever-test-for-debilitating-condition https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24550/scientists-develop-first-accurate-blood-test-to-detect-chronic-fatigue-syndrome https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24553/first-proposed-blood-test-for-chronic-fatigue-syndrome-what-scientists-think https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24556/this-prostate-cancer-test-is-270-better-than-psa https://www.oxfordbiodynamics.com/media-center/in-the-news/detail/24559/could-this-be-the-first-definitive-test-for-mecfs https://www.oxfordbiodynamics.com/media-center/publications/detail/24481/whole-genome-3d-blood-biopsy-profiling-of-canine-cancers-development-and-validation-of-episwitch-multi-choice-array-based-diagnostic-test https://www.oxfordbiodynamics.com/media-center/publications/detail/24435/development-and-validation-of-blood-based-predictive-biomarkers-for-response-to-pd-1pd-l1-checkpoint-inhibitors-evidence-of-a-universal-systemic-core-of-3d-immunogenetic-profiling-across-multiple-oncological-indications https://www.oxfordbiodynamics.com/media-center/publications/detail/24391/circulating-chromosome-conformation-signatures-significantly-enhance-psa-positive-predicting-value-and-overall-accuracy-for-prostate-cancer-detection https://www.oxfordbiodynamics.com/media-center/publications/detail/24367/omics-and-multi-omics-analysis-for-the-early-identification-and-improved-outcome-of-patients-with-psoriatic-arthritis https://www.oxfordbiodynamics.com/media-center/publications/detail/24369/genomic-biomarkers-in-peripheral-blood-from-patients-enrolled-in-the-javelin-bladder-100-trial-of-avelumab-first-line-maintenance-in-advanced-urothelial-carcinoma https://www.oxfordbiodynamics.com/media-center/publications/detail/24368/monocytes-acquire-prostate-cancer-specific-chromatin-conformations-upon-indirect-co-culture-with-prostate-cancer-cells https://www.oxfordbiodynamics.com/media-center/publications/detail/24364/targeting-3d-chromosomal-architecture-at-the-rank-loci-to-suppress-myeloma-driven-osteoclastogenesis https://www.oxfordbiodynamics.com/media-center/publications/detail/24370/chromatin-conformation-changes-in-peripheral-blood-can-detect-prostate-cancer-and-stratify-disease-risk-groups https://www.oxfordbiodynamics.com/media-center/publications/detail/24371/3d-genomic-capture-of-regulatory-immuno-genetic-profiles-in-covid-19-patients-for-prognosis-of-severe-covid-disease-outcome https://www.oxfordbiodynamics.com/media-center/publications/detail/24372/development-and-validation-of-blood-based-predictive-biomarkers-for-response-to-pd-l-1-checkpoint-inhibitors https://www.oxfordbiodynamics.com/media-center/publications/detail/24373/development-and-validation-of-blood-based-prognostic-biomarkers-for-severity-of-covid-disease-outcome-using-episwitch-3d-genomic-regulatory-immuno-genetic-profiling https://www.oxfordbiodynamics.com/media-center/publications/detail/24374/genomic-architecture-differences-at-the-htt-locus-associated-with-symptomatic-and-pre-symptomatic-cases-of-huntingtons-disease-in-a-pilot-study https://www.oxfordbiodynamics.com/media-center/publications/detail/24375/comparative-molecular-cell-of-origin-classification-of-diffuse-large-b-cell-lymphoma-based-on-liquid-and-tissue-biopsies https://www.oxfordbiodynamics.com/media-center/publications/detail/24448/current-advances-in-epigenetics https://www.oxfordbiodynamics.com/media-center/publications/detail/24376/the-prospective-study-of-epigenetic-regulatory-profiles-in-sport-and-exercise-monitored-through-chromosome-conformation-signatures https://www.oxfordbiodynamics.com/media-center/publications/detail/24365/radicavaedaravone-findings-in-biomarkers-from-als-refine-als-protocol-and-study-design https://www.oxfordbiodynamics.com/media-center/publications/detail/24377/development-and-validation-of-baseline-predictive-biomarkers-for-response-to-avelumab-in-second-line-2l-non-small-cell-lung-cancer-nsclc-using-episwitch-epigenetic-profiling https://www.oxfordbiodynamics.com/media-center/publications/detail/24378/development-and-validation-of-baseline-predictive-biomarkers-for-response-to-immuno-checkpoint-treatments-in-the-context-of-multi-line-and-multi-therapy-cohorts-using-episwitch-epigenetic-profiling https://www.oxfordbiodynamics.com/media-center/publications/detail/24379/ectopic-gene-deregulations-and-chromosome-conformations-integrating-novel-molecular-testing-into-clinical-applications-from-leukemias-to-gliomas https://www.oxfordbiodynamics.com/media-center/publications/detail/24380/genomic-architecture-differences-at-the-htt-locus-underlie-symptomatic-and-pre-symptomatic-cases-of-huntingtons-disease https://www.oxfordbiodynamics.com/media-center/publications/detail/24381/initial-identification-of-a-blood-based-chromosome-conformation-signature-for-aiding-in-the-diagnosis-of-amyotrophic-lateral-sclerosis https://www.oxfordbiodynamics.com/media-center/publications/detail/24382/the-chromosomal-conformation-signature-a-new-kid-on-the-block-in-als-biomarker-research https://www.oxfordbiodynamics.com/media-center/publications/detail/24383/chromosome-conformation-signatures-define-predictive-markers-of-inadequate-response-to-methotrexate-in-early-rheumatoid-arthritis https://www.oxfordbiodynamics.com/media-center/publications/detail/24384/epigenetic-chromatin-conformation-changes-in-peripheral-blood-can-detect-thyroid-cancer https://www.oxfordbiodynamics.com/media-center/publications/detail/24385/white-blood-cells-from-prostate-cancer-patients-carry-distinct-chromosome-conformations https://www.oxfordbiodynamics.com/media-center/publications/detail/24386/super-enhancers-and-broad-h3k4me3-domains-form-complex-gene-regulatory-circuits-involving-chromatin-interactions https://www.oxfordbiodynamics.com/media-center/publications/detail/24387/systemic-epigenetic-biomarkers-for-als-improve-early-diagnosis https://www.oxfordbiodynamics.com/media-center/publications/detail/24388/a-pilot-study-of-chromosomal-aberrations-and-epigenetic-changes-in-peripheral-blood-samples-to-identify-patients-with-melanoma https://www.oxfordbiodynamics.com/media-center/publications/detail/24389/chromatin-barcodes-as-biomarkers-for-melanoma https://www.oxfordbiodynamics.com/media-center/publications/detail/24390/clinical-and-statistical-considerations-in-personalized-medicine-1st-ed https://www.oxfordbiodynamics.com/media-center/publications/detail/24366/formation-of-distinct-chromatin-conformation-signatures-epigenetically-regulate-macrophage-activation https://www.oxfordbiodynamics.com/media-center/publications/detail/24500/development-and-evaluation-of-blood-based-prognostic-biomarkers-for-covid-disease-outcomes-using-episwitch-3-dimensional-genomic-regulatory-immuno-genetic-profiling https://www.oxfordbiodynamics.com/media-center/publications/detail/24501/a-new-blood-based-epigenetic-diagnostic-biomarker-test-episwitch-nst-with-high-sensitivity-and-positive-predictive-value-for-colorectal-cancer-and-precancerous-polyps https://www.oxfordbiodynamics.com/media-center/publications/detail/24507/evaluation-of-episwitch-in-predicting-immunotherapy-response-in-hepatocellular-carcinoma-and-gastrointestinal-tumors https://www.oxfordbiodynamics.com/media-center/publications/detail/24513/a-new-blood-based-epigenetic-diagnostic-biomarker-test-episwitch-nst-with-high-sensitivity-and-positive-predictive-value-for-colorectal-cancer-and-precancerous-polyps https://www.oxfordbiodynamics.com/media-center/publications/detail/24531/rising-trends-in-prostate-cancer-among-asian-men-global-concerns-and-diagnostic-solutions https://www.oxfordbiodynamics.com/media-center/publications/detail/24535/paradigm-lost https://www.oxfordbiodynamics.com/media-center/publications/detail/24536/episwitch-pse-blood-test-reduces-unnecessary-prostate-biopsies-a-real-world-clinical-utility-study https://www.oxfordbiodynamics.com/media-center/publications/detail/24540/blood-epigenetic-biomarker-associations-with-tumor-immunophenotype-in-patients-with-urothelial-carcinoma-from-javelin-bladder-100 https://www.oxfordbiodynamics.com/media-center/publications/detail/24547/clinical-utility-of-the-episwitch-cirt-test-to-guide-immunotherapy-across-solid-tumors-interim-results-from-the-prowes-study https://www.oxfordbiodynamics.com/media-center/publications/detail/24549/development-and-validation-of-blood-based-diagnostic-biomarkers-for-myalgic-encephalomyelitischronic-fatigue-syndrome-mecfs-using-episwitch-3-dimensional-genomic-regulatory-immuno-genetic-profiling https://www.oxfordbiodynamics.com/careers https://www.oxfordbiodynamics.com/contact-us https://www.oxfordbiodynamics.com/privacy-policy https://www.oxfordbiodynamics.com/disclaimer https://www.oxfordbiodynamics.com/sitemap https://www.oxfordbiodynamics.com/cookies-policy